These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7791119)

  • 1. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells.
    Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1442-9. PubMed ID: 7791119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation.
    Yue TL; Wang X; Gu JL; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1995 Dec; 294(2-3):585-91. PubMed ID: 8750722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
    Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
    Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
    Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
    J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol inhibits vascular smooth muscle cell proliferation.
    Sung CP; Arleth AJ; Ohlstein EH
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
    Yue TL; Mckenna PJ; Lysko PG; Gu JL; Lysko KA; Ruffolo RR; Feuerstein GZ
    Eur J Pharmacol; 1994 Jan; 251(2-3):237-43. PubMed ID: 8149979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension.
    Fujio H; Nakamura K; Matsubara H; Kusano KF; Miyaji K; Nagase S; Ikeda T; Ogawa A; Ohta-Ogo K; Miura D; Miura A; Miyazaki M; Date H; Ohe T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):250-5. PubMed ID: 16495763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol inhibits endothelin-1 biosynthesis in cultured human coronary artery endothelial cells.
    Ohlstein EH; Arleth AJ; Storer B; Romanic AM
    J Mol Cell Cardiol; 1998 Jan; 30(1):167-73. PubMed ID: 9500873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
    Yue TL; McKenna PJ; Gu JL; Cheng HY; Ruffolo RE; Feuerstein GZ
    Cardiovasc Res; 1994 Mar; 28(3):400-6. PubMed ID: 7909721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol inhibits tumor necrosis factor-alpha-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells.
    Chen JW; Lin FY; Chen YH; Wu TC; Chen YL; Lin SJ
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2075-81. PubMed ID: 15374848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells: role of reactive oxygen species.
    Sun Y; Chen X
    Fundam Clin Pharmacol; 2011 Oct; 25(5):572-9. PubMed ID: 21077940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
    Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
    Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of oxidized-low density lipoprotein on expression of urotensin II receptor GPR14 in rat aortic smooth muscle cells].
    Wang ZJ; Ding WH; Shi LB; Bu DF; Ren ZW; Tang CS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):242-6. PubMed ID: 16677503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmembrane calcium flux regulates LDL oxidation by arterial smooth muscle cells.
    Wells KE; Miguel R; Alexander JJ
    J Surg Res; 1997 Feb; 67(2):126-31. PubMed ID: 9073558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
    Feuerstein GZ; Ruffolo RR
    Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of Huoxue injection on oxidized low-density lipoprotein induced activation of human umbilical vein endothelial cells].
    Zhu LQ; Wang SR; Zhao MJ; Cui W; Niu FL
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1617-21. PubMed ID: 18837329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cells.
    Nakajima T; Ma J; Iida H; Iwasawa K; Jo T; Omata M; Nagai R
    Jpn Heart J; 2003 Nov; 44(6):963-78. PubMed ID: 14711191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
    Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.
    Sung CP; Arleth AJ; Eichman C; Truneh A; Ohlstein EH
    J Pharmacol Exp Ther; 1997 Nov; 283(2):910-7. PubMed ID: 9353413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.